Elaine Ullian, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,000 shares at $122.96 ($613K) on 2015-01-02, disclosed to the SEC on 2015-01-06.
Scheduled sale ($613k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.91 | 100 | $12K | 1.9% |
| 2 | $122.15 | 1,700 | $208K | 33.9% |
| 3 | $122.96 | 3,100 | $381K | 62.2% |
| 4 | $123.57 | 100 | $12K | 2.0% |
| Total | $122.62 avg | 5,000 | $613K | 100% |
| Filing → |
| HOLX | SELL | 2017-07-06 | $801K | — | Filing → |
| HOLX | SELL | 2017-06-06 | $786K | — | Filing → |
| HOLX | SELL | 2017-05-05 | $799K | — | Filing → |